Literature DB >> 11083443

Measurement of serum hyaluronic acid as a sensitive marker of liver fibrosis in biliary atresia.

T Hasegawa1, T Kimura, M Hoki, A Okada, S Mushiake, M Yagi, K Imura.   

Abstract

PURPOSE: The aim of this study was to clarify whether serum hyaluronic acid level (SHA) can reflect the degree of liver fibrosis in biliary atresia (BA).
METHODS: SHA was measured in 44 postoperative BA patients at 7 months to 22 years of age, with sandwich enzyme method (Hy-A 100 kit). SHA was compared with T.Bil (group 1, T Bil < 2; group 2, 2 < or = T Bil < 5; group 3, T Bil > or = 5 mg/dL), fibrosis score (0-6, the number of abnormal values among Alb, PT, ChE, T Chol, Fischer's ratio, prealbumin), and histologic grading (0-IV).
RESULTS: SHA was 499.8 +/- 332.5 in group 3, significantly higher than in the control, group 1, or group 2. As fibrosis score rose, SHA became higher, and SHA in Score 6 (430.1 +/- 366.1 ng/mL) and score-5 (172.9 +/- 141.8 ng/mL) was significantly higher than in the control and other scores, respectively. As the histologic grade rose, SHA became higher, and SHA in grade IV (444.8 +/- 323.5 ng/mL) and grade III (166.0 +/- 70.3 ng/mL) was significantly higher than in the control or other Grades. Serial change of SHA since before HPE was parallel to the clinical course in 8 patients.
CONCLUSION: SHA may be a useful serum marker reflecting the degree of liver fibrosis in BA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083443     DOI: 10.1053/jpsu.2000.18342

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  11 in total

1.  Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis.

Authors:  Dariusz Marek Lebensztejn; Elzbieta Skiba; Jolanta Tobolczyk; Maria Elzbieta Sobaniec-Lotowska; Maciej Kaczmarski
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha.

Authors:  Dariusz-Marek Lebensztejn; Maria-Elzbieta Sobaniec-Lotowska; Maciej Kaczmarski; Michael Voelker; Detlef Schuppan
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  Indication for redo hepatic portoenterostomy for insufficient bile drainage in biliary atresia: re-evaluation in the era of liver transplantation.

Authors:  T Hasegawa; T Kimura; T Sasaki; A Okada; S Mushiake
Journal:  Pediatr Surg Int       Date:  2003-04-03       Impact factor: 1.827

4.  Oral administration of eicosapentaenoic acid suppresses liver fibrosis in postoperative patients with biliary atresia.

Authors:  Wataru Sumida; Hiroo Uchida; Takahisa Tainaka; Chiyoe Shirota; Akinari Hinoki; Takazumi Kato; Kazuki Yokota; Kazuo Oshima; Ryo Shirotuki; Kosuke Chiba; Yujiro Tanaka
Journal:  Pediatr Surg Int       Date:  2018-07-28       Impact factor: 1.827

5.  Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia.

Authors:  Takehisa Ueno; Tasuku Kodama; Yuki Noguchi; Ryuta Saka; Yuichi Takama; Yuko Tazuke; Kazuhiko Bessho; Hiroomi Okuyama
Journal:  Pediatr Surg Int       Date:  2018-08-20       Impact factor: 1.827

6.  Histological classification of liver fibrosis and its impact on the postoperative clinical course of patients with congenital dilatation of the bile duct.

Authors:  Toshimichi Hasegawa; Takuya Kimura; Yoshiyuki Ihara; Masahiro Fukuzawa
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

7.  Serum hyaluronan as a marker reflecting the severity of cirrhosis and portal hypertension in postoperative biliary atresia.

Authors:  Voranush Chongsrisawat; Prachya Kongtawelert; Wannarat Tongsoongnoen; Pisit Tangkijvanich; Paisarn Vejchapipat; Yong Poovorawan
Journal:  Pediatr Surg Int       Date:  2004-10       Impact factor: 1.827

8.  Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis.

Authors:  Lin He; Dennis Kai Ming Ip; Greta Tam; Vincent Chi Hang Lui; Paul Kwong Hang Tam; Patrick Ho Yu Chung
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

Review 9.  Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies.

Authors:  Olga Hilda Orasan; George Ciulei; Angela Cozma; Madalina Sava; Dan Lucian Dumitrascu
Journal:  Clujul Med       Date:  2016-01-15

10.  Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp.

Authors:  Laura M Keller; Stephanie Eighmy; Cun Li; Lauryn Winter; Jay Kerecman; Zachary Goodman; Naveen Mittal; Cynthia L Blanco
Journal:  PLoS One       Date:  2020-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.